In a 44-year-old woman with severe hypoxemic respiratory failure, recent productive cough, leukocytosis that improved with antibiotics, right lower lobe atelectasis, a dilated pulmonary artery on CT, normal pulmonary capillary wedge pressure, elevated mean pulmonary artery pressure, and high pulmonary vascular resistance, what is the most likely diagnosis: acute respiratory distress syndrome, heart failure with reduced ejection fraction, pneumonia, or precapillary pulmonary hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Precapillary Pulmonary Hypertension

The most likely diagnosis is precapillary pulmonary hypertension. The hemodynamic profile definitively establishes this: mean PA pressure of 40 mmHg, pulmonary capillary wedge pressure (PCWP) of 10 mmHg (≤15 mmHg), and pulmonary vascular resistance (PVR) of 436 dynes·sec·cm⁻⁵ (approximately 5.5 Wood units, well above the threshold of >3 WU) 1.

Hemodynamic Classification

The patient meets the precise criteria for precapillary pulmonary hypertension as defined by the ESC/ERS guidelines 1:

  • Mean PA pressure ≥25 mmHg (she has 40 mmHg)
  • PCWP ≤15 mmHg (she has 10 mmHg)
  • PVR >3 Wood units (she has ~5.5 WU)

This hemodynamic pattern excludes postcapillary causes and confirms true pulmonary vascular disease rather than left heart disease or volume overload.

Why Not the Other Diagnoses?

ARDS is excluded because:

  • CT angiography showed no infiltrates, which are required for ARDS diagnosis
  • While ARDS can cause pulmonary hypertension 2, it does so in the context of bilateral infiltrates and severe parenchymal lung disease
  • The isolated atelectasis does not explain the severe, persistent hypoxemia or the markedly elevated PVR

Heart failure with reduced ejection fraction is excluded because:

  • Normal PCWP of 10 mmHg rules out elevated left-sided filling pressures
  • Cardiac output is preserved at 5.5 L/min with normal cardiac index of 2.6
  • The hemodynamic pattern is precapillary, not postcapillary 1

Pneumonia alone is excluded because:

  • Leukocytosis improved with antibiotics (14,000→10,000), suggesting infection is controlled
  • No infiltrates on CT angiography
  • Persistent severe hypoxemia requiring FiO2 80% despite improving inflammatory markers is inconsistent with resolving pneumonia
  • The markedly elevated PVR (>5 WU) cannot be explained by pneumonia alone

Clinical Context

The dilated pulmonary artery on CT is a key structural finding that supports chronic pulmonary vascular remodeling rather than an acute infectious or inflammatory process. The PCWP of 10 mmHg is reliable for excluding left heart disease 3, particularly since PCWP ≤15 mmHg has 89% sensitivity for correctly identifying precapillary PH.

Important Caveats

  • The productive cough and fever may represent a triggering event that unmasked underlying pulmonary hypertension, or a concurrent infection in a patient with pre-existing PH
  • The right lower lobe atelectasis is likely secondary to the severe PH and right heart dysfunction, not the primary pathology
  • Further workup should focus on determining the etiology of the precapillary PH (idiopathic PAH, connective tissue disease, chronic thromboembolic disease, etc.) 1
  • Despite poor acoustic windows on echocardiography, the PA catheter data provides definitive hemodynamic diagnosis 4

The combination of severe hypoxemia, normal PCWP, markedly elevated PVR, and absence of parenchymal lung disease on CT makes precapillary pulmonary hypertension the only diagnosis that fits the complete clinical and hemodynamic picture.

Related Questions

In an 83-year-old woman with a 2 cm lung nodule and severe pulmonary hypertension (right‑ventricular systolic pressure 57 mm Hg), would she benefit from right‑heart catheterization?
In a patient with right-sided heart failure, WHO Group 3 pulmonary hypertension, and recurrent desaturation, what is the significance of an elevated D-dimer (~1350 ng/mL) and how should it be managed?
Does pulmonary capillary wedge pressure reflect left ventricular end-diastolic pressure?
What does an elevated pulmonary capillary wedge pressure indicate?
In a patient with a 2D echocardiogram showing normal left atrium and left ventricle, no mitral regurgitation, grade I left ventricular systolic dysfunction, severe tricuspid regurgitation, severe pulmonary arterial hypertension with a D‑shaped interventricular septum and pulmonary artery systolic pressure of 84 mmHg, and a hemoglobin of 6.8 g/dL, should a component of left‑heart disease or a hyperdynamic circulation be considered?
What medication is recommended for treating throat pain and headache due to a viral infection?
In a 70-year-old man with COPD exacerbation on mechanical ventilation (rate 14 breaths/min, tidal volume 550 mL, FiO₂ 40%, PEEP 8 cm H₂O) who develops subcutaneous emphysema and CT shows air tracking into the chest wall and back muscles, what is the best next step in management?
What is the recommended antenatal care plan for a high‑risk pregnant patient, including initial assessment, monitoring schedule, laboratory testing, medication regimen, and postpartum follow‑up?
Is heart failure with reduced ejection fraction (HFrEF) the same as systolic heart failure?
What are some manufacturers of clinical‑grade edema leg wraps that provide high compression?
In a 62-year-old woman with stage III breast cancer, severe hypercalcemia, acute kidney injury (creatinine >4 mg/dL), and current treatment with isotonic saline hydration, furosemide diuresis, and subcutaneous calcitonin, which is the most appropriate next step: continue calcitonin, initiate denosumab, start renal replacement therapy, or administer zoledronic acid?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.